Healthcare & Medical Devices Global On demand · 24-48h

Global Gelfoam Sponge Market Strategic Research Report

Global Gelfoam Sponge Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Gelfoam Sponge Market
$6682025
4.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Large Size, Small Size

By Application: Hospital, Clinic, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Pfizer, B Braun, Amd-Ritmed, Angel Life Science, Cutanplast, Aegis Lifesciences, HHAO TECHNOLOGY, Genco Tibbi, ETHICON, Johnson & Johnson, Healthium, Goodwill Lifesciences, Eucare

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 121 pages
Market size 2025
$668
Million USD
Forecast CAGR
4.8%
2025-2032
Forecast 2032
$927.5
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Gelfoam Sponge market size is predicted to grow from US$ 668 million in 2025 to US$ 920 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.

In 2025, global gelfoam sponge production reached approximately 27 m units, the average price is 25 usd/ unit. Gelfoam sponge is a white or yellowish, sterile, water-insoluble sponge-like material made of gelatin and used mainly as a topical hemostatic in the medical field. It is also known as absorbent gelatin sponge, its core component is gelatin, which is a macromolecular hydrocolloid obtained from partial hydrolysis of collagen extracted from animal skin, bone and other tissues.

Market Concentration and Key Players:

Internationally, the market concentration of gelatin sponge is relatively high, mainly concentrated in developed countries in Europe, America and Japan. For example, large manufacturers such as Denso and Smart Eye; from the domestic point of view, gelatin sponge still has a lot of room for development.

Manufacturing Processes and Market Trends:

The core of gelatin sponge production process lies in the use of gelatin solution obtained from animal collagen hydrolysis to construct stable three-dimensional porous structure through physical foaming and freeze-drying technology, and its market trend is closely connected with the growth of global medical demand and technological innovation.

The typical manufacturing process begins with the preparation of gelatin solution, followed by the injection of gas under strict control of stirring speed and temperature to form uniform gelatin foam, followed by injection of foam into the mold and rapid freeze setting at very low temperature, and finally by freeze drying to remove moisture and complete solidification. This process may also introduce modified processes such as oxidative crosslinking to improve the mechanical strength and biocompatibility of the sponge, avoiding the use of traditional chemical crosslinking agents.

In terms of market trends, the growth of China market is more significant. This increase is mainly due to the popularity of minimally invasive surgery, medical needs caused by the aging population and the continuous upgrading of the medical system. In the future, the industry will focus more on the functionalization and greening of products, such as the development of smart sponges with antibacterial or drug-carrying functions, and the adoption of environmentally friendly raw materials and processes to reduce environmental impact.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Gelfoam Sponge market?

What factors are driving Gelfoam Sponge market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Gelfoam Sponge market opportunities vary by end market size?

How does Gelfoam Sponge break out by Size, by Application?

This report presents a comprehensive overview of the global Gelfoam Sponge market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Size

  • Large Size
  • Small Size

Segment by Shape

  • Sheet
  • Massive
  • Powder

Segment by Function

  • Hemostatic
  • Stent

Segment by Application

  • Hospital
  • Clinic
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Gelfoam Sponge market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Gelfoam Sponge Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$668
2025
Forecast
$927.5
2032
CAGR
4.8%
2025–2032
リージョン
5
global
Key companies
PfizerB BraunAmd-RitmedAngel Life ScienceCutanplastAegis LifesciencesHHAO TECHNOLOGYGenco Tibbi
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Large SizeSmall Size
By Application
HospitalClinicOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Large Size
  • 3.1.3 Small Size
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Pfizer
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 B Braun
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Amd-Ritmed
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Angel Life Science
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Cutanplast
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Aegis Lifesciences
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 HHAO TECHNOLOGY
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Genco Tibbi
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 ETHICON
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Johnson & Johnson
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Healthium
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Goodwill Lifesciences
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Eucare
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Gelfoam Sponge market size?
The global Gelfoam Sponge market is estimated at US$ 668 million in 2025 (base year) and is projected to reach US$ 920 million by 2032.
What growth rate is expected for the Gelfoam Sponge market through 2032?
The market is expected to grow at a CAGR of 4.8% from 2026 to 2032, expanding from US$ 668 million in 2025 to US$ 920 million in 2032, roughly 1.4 times its base-year value.
How is Gelfoam Sponge defined?
In 2025, global gelfoam sponge production reached approximately 27 m units, the average price is 25 usd/ unit. Gelfoam sponge is a white or yellowish, sterile, water-insoluble sponge-like material made of gelatin and used mainly as a topical hemostatic in the medical field. It is also known as absorbent gelatin sponge, its core component is gelatin, which is a macromolecular hydrocolloid obtained from partial hydrolysis of collagen extracted from animal skin, bone and other tissues.
How is the Gelfoam Sponge market segmented by size?
By size, the market is segmented into Large Size and Small Size.
What are the key applications of Gelfoam Sponge?
Key applications covered include Hospital, Clinic and Others.
Which companies are profiled in the Gelfoam Sponge market report?
Key players profiled include Pfizer, B Braun, Amd-Ritmed, Angel Life Science, Cutanplast, Aegis Lifesciences, HHAO TECHNOLOGY and Genco Tibbi, among 13 companies covered in total.
What geographies does the Gelfoam Sponge market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Gelfoam Sponge?
What factors are driving Gelfoam Sponge market growth, globally and by region?
Who should buy the Gelfoam Sponge market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Gelfoam Sponge market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.